The novel approach of the medication represents a major development in the care of type 2 diabetes. Distinct from existing drugs, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide665861.liberty-blog.com/42305304/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment